Risk Factors for Chronic Postoperative Pain After Elective Nephrectomy

March 24, 2026 updated by: İlayda Bilgili Altuntaş, Istanbul University - Cerrahpasa

Risk Factors Affecting Chronic Postoperative Pain After Elective Nephrectomy

Chronic postoperative pain (CPP) is typically defined as pain persisting for 3 months or more after surgery[1]. CPP is a common and increasingly prevalent morbidity, leading to long-term psychological issues, reduced quality of life, and impaired functionality[2]. To reduce the incidence of CPP, high-risk patients are identified, and various surgical techniques, pharmacological agents, and regional anesthesia techniques are employed[3].

The primary aim of our study is to scale chronic pain at 1 hour, 3 months, and 1 year post-nephrectomy using the Numeric Rating Scale (NRS), ranging from 0 to 10. The secondary aim is to evaluate the effects of factors influencing chronic postoperative pain on the NRS scores.

Study Overview

Detailed Description

Patients gender, age, height(m), weight(kg), body mass index(kg/m2), diagnosis, smoking and alcohol history, comorbidities, surgical technique and duration, complications, lymph node dissection, thrombectomy, adrenalectomy, amount of bleeding(cc), need for blood transfusion, need for intensive care, analgesia technique used, amount of opioids and non-opioid analgesics used perioperatively, amount of vasopressors used, heart rate(bpm) and mean arterial pressure(mmHg) at induction, post-intubation, post-extubation, and 1 hour postoperatively, presence of postoperative pain, chronic analgesic use history(more than 3 uses per week), presence of fibromyalgia, frequent urinary tract infections, diagnosed with central sensitization disorders, bruxism, depression-panic attacks, allergic asthma, irritable bowel syndrome, and migraines will be recorded. The effects of these factors on NRS scores at 1 hour, 3 months, and 1 year postoperatively will be examined.

Study Type

Observational

Enrollment (Actual)

204

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients aged 18-90 years, ASA I-IV, undergoing elective nephrectomy under general anesthesia will be included in the study.

Description

Inclusion Criteria: -Patients aged 18-90 years,

  • ASA I-IV,
  • undergoing elective nephrectomy under general anesthesia will be included in the study.

Exclusion Criteria:

  • Patients who cannot be reached by phone and hose who die within the 1-year postoperative period will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Painfull: patients with Numeric Rating Score equal or higher than 4
The patients are asked to rate their pain according to the Numeric Rating Scale (0=no pain; 10=worse possible pain), and patients with NRS equal or higher than 4 are defined as "painfull".
The patients are asked to rate their pain according to the Numeric Rating Scale (0=no pain; 10=worse possible pain).
Pain-free: patients with Numeric Rating Score lower than 4
The patients are asked to rate their pain according to the Numeric Rating Scale (0=no pain; 10=worse possible pain), and patients with NRS lower than 4 are defined as "pain-free".
The patients are asked to rate their pain according to the Numeric Rating Scale (0=no pain; 10=worse possible pain).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS 1 hour
Time Frame: 1 hour after the end of the surgery
The patients are asked to rate their pain according to the Numeric Rating Scale (0=no pain; 10=worse possible pain). Patients with NRS equal or higher than 4 are defined as painfull; and, patients with NRS lower than 4 are defined as pain-free
1 hour after the end of the surgery
NRS 3 months
Time Frame: 3 months after the surgery
The patients are asked to rate their pain according to the Numeric Rating Scale (0=no pain; 10=worse possible pain). Patients with NRS equal or higher than 4 are defined as painfull; and, patients with NRS lower than 4 are defined as pain-free
3 months after the surgery
NRS 1 year
Time Frame: 1 year after the surgery
The patients are asked to rate their pain according to the Numeric Rating Scale (0=no pain; 10=worse possible pain). Patients with NRS equal or higher than 4 are defined as painfull; and, patients with NRS lower than 4 are defined as pain-free
1 year after the surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
age
Time Frame: At the time of preoperative assesment
Age of the patiens as years
At the time of preoperative assesment
height
Time Frame: At the time of preoperative assesment
Height of the patiens as meter
At the time of preoperative assesment
BMI
Time Frame: At the time of preoperative assesment
body mass index of the patiens as kg/m2
At the time of preoperative assesment
smoking
Time Frame: At the time of preoperative assesment
Data of the patient if they are smoking or not
At the time of preoperative assesment
Amount of opioid and non-opioid analgesics used perioperatively
Time Frame: At the time of perioperative assesment
Amount of opioid and non-opioid analgesics used perioperatively
At the time of perioperative assesment
Gender
Time Frame: At the time of preoperative assesment
Woman or man
At the time of preoperative assesment
Comorbidities
Time Frame: At the time of preoperative assesment
hipertension, diabetus mellitus, asthma or cardiac disease etc.
At the time of preoperative assesment
surgical technique
Time Frame: At the time of perioperative assesment
radical or partial nephrectomy and open or laparoscopic nephrectomy
At the time of perioperative assesment
surgical duration
Time Frame: The time recorded at the end of the surgery will be reported
How long does the surgery take in minutes?
The time recorded at the end of the surgery will be reported
additional procedures next to the nephrectomy
Time Frame: At the time of perioperative assesment
lymph node dissection, thrombectomy, adrenalectomy procedures used
At the time of perioperative assesment
need for blood transfusion
Time Frame: At the time of perioperative assesment
How many blood product tranfusions were required?
At the time of perioperative assesment
need for intensive care units
Time Frame: At the time of postoperative assesment, the data evaluated at the end of the surgery will be reported
Whether there is a need for intensive care after surgery
At the time of postoperative assesment, the data evaluated at the end of the surgery will be reported
Analgesia technique
Time Frame: At the time of perioperative assesment
Epidural analgesia or intravenous analgesia was used as analgesic technique
At the time of perioperative assesment
Amount of vasopressors used
Time Frame: At the time of perioperative assesment
Amount of vasopressors used at the perioperative period
At the time of perioperative assesment
Value of postoperative acute pain score on NRS score
Time Frame: 1 hour postoperative period
Value of postoperative acute pain score on NRS score(0:no pain, 10:the worst pain imaginable)
1 hour postoperative period
Chronic analgesic use history
Time Frame: 1 year before the operation
More than 3 uses per a week
1 year before the operation
Clinical conditions that will be reported under the title of central sensitization disorder
Time Frame: At the time of preoperative assesment
Presence of fibromyalgia, frequent urinary tract infection, bruxism, diagnosed with depression-panic attack, allergic asthma, irritable bowel syndrome and migraines will be recorded.
At the time of preoperative assesment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Aylin Nizamoglu, Doctor, Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine
  • Study Chair: Safak E Erbabacan, associate professor, Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine
  • Study Chair: Fatis Altindas, Professor, Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine
  • Principal Investigator: İlayda Bilgili Altuntaş, Physician, Istanbul Univerisity-Cerrahpasa Cerrahpasa Faculty of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2025

Primary Completion (Actual)

March 24, 2026

Study Completion (Actual)

March 24, 2026

Study Registration Dates

First Submitted

September 25, 2024

First Submitted That Met QC Criteria

November 2, 2024

First Posted (Actual)

November 5, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Numeric Rating Scale

Subscribe